After reading this chapter, you should be able to:
The interaction between a naïve T cell and an antigen-presenting cell (APC) is the initiating event of the adaptive immune response. Prior to this, the innate immune system was alerted to infection or tissue damage, and antigen-presenting cells were activated via pattern recognition receptors. These APCs may have engulfed extracellular (or opsonized intracellular) pathogens, or they may have been infected with an intracellular pathogen. In either case, they have processed and presented peptides from these pathogens in complex with surface MHC class I and class II molecules, and migrated to secondary lymphoid tissue, including local (draining) lymph nodes, Peyer’s patches (see Chapter 13), and/or the spleen. Within these secondary lymphoid tissues APCs settled in the T-cell zones, joining networks of resident APCs, to be continually scanned by roving naïve CD8+ and CD4+ T cells, which recognize MHC class I–peptide and MHC class II–peptide complexes, respectively. (Chapter 14 provides an overview of the initiation of an immune response in secondary lymphoid tissue.)
We have seen that each mature T cell expresses a unique antigen receptor assembled via random gene rearrangement (Chapter 6) during T-cell development in the thymus. Positive and negative selection in the thymus ensures that the mature, naïve T cells that enter the circulation are largely tolerant to self antigens, and restricted to self MHC (Chapter 8). Some naïve T cells commit to the CD8+ cytotoxic T-cell lineage, others to the CD4+ helper T-cell lineage. If, during their migration through secondary lymphoid organs, naïve CD8+ or CD4+ T cells bind tightly to an MHC-peptide complex expressed by an activated dendritic cell, they become activated by signals generated through their T-cell receptors (TCRs). As we will learn in this chapter, TCR signals in concert with costimulatory and cytokine signals stimulate naïve T cells to proliferate and differentiate into effector T cells.
In this chapter, we specifically review the cellular and molecular events that activate naïve T cells and investigate the variety of costimulatory interactions that play an important role in determining the outcome of T cell–APC interactions. We then discuss the end result of naïve T-cell activation—the development of distinct effector and memory T-cell subsets—focusing primarily on the various fates and functions of the CD4+ helper T-cell (TH) lineages that drive both B- and T-cell adaptive responses (Overview Figure 10-1). As you know, naïve CD8+ T cells differentiate into cytotoxic cells in response to engagement of MHC class I–peptide combinations. Although we describe the initial activation and differentiation of CD8+ T cells in this chapter, we spend more time on their cytotoxic effector functions in Chapter 12.
Here, we explore the surprising number of helper lineages that a naïve CD4+ T cell can adopt (TH1, TH2, TH17, TFH, pTREG, TH9, and more), and broadly discuss their functions. We also examine what regulates a CD4+ T cell’s lineage decision, and how it is influenced by the response of the innate immune system to specific pathogens and antigens. We close the chapter with a discussion of the generation of T-cell memory, introducing the multiple memory subsets and current thinking about their origin and function.
A Classic Experiment box describes the basic research behind the discovery of the costimulatory molecule CD28, an essential participant in naïve T-cell activation. The first Clinical Focus box describes the development of an exciting new immunotherapy for cancer that took advantage of the discovery of a relative of CD28 that inhibited rather than enhanced T-cell activation. Together, these boxes illustrate the powerful connection between basic research and clinical advances. This partnership is the basis for translational research, an effort to bring the bench to the “bedside” that has captured the imagination of many biomedical investigators and clinicians.
The Advances box describes recent insights into the origin of regulatory T cells that play a role in maintaining maternal-fetal tolerance during pregnancy. The second Clinical Focus box discusses how a disease, an “experiment of nature,” has helped us to better understand the basic biology and physiological function of one of the helper cell subsets (TH17) introduced in this chapter.